Clinical Trials Directory

Trials / Sponsors / Ichnos Sciences SA

Ichnos Sciences SA

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Relapsed/Refractory Multiple Myeloma
Phase 12023-11-01
TerminatedPhase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Phase 1 / Phase 22022-09-27
TerminatedStudy of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer
Breast Cancer
Phase 1 / Phase 22020-04-08
CompletedPhase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermati
Moderate to Severe Atopic Dermatitis
Phase 22018-05-31
CompletedStudy of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma
Relapsed/Refractory Multiple Myeloma
Phase 12017-10-25
TerminatedPhase 1 Study of Single Agent GBR 1302 in Subjects With HER2 Positive Cancers
HER2 Expressing Solid Tumours
Phase 12016-05-01
CompletedTo Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic De
Atopic Dermatitis
Phase 22016-03-01